8min chapter

Bloomberg Intelligence cover image

Dow Chemical, Fed Decision, Oprah

Bloomberg Intelligence

CHAPTER

Oprah's Impact on Weight Loss Drugs

The chapter delves into Oprah's involvement with promoting GLP-1 drugs for weight loss, despite not disclosing the specific one she uses. It discusses her association with these medications and the evolving dynamics of the weight loss industry, including the intersection with plastic surgery trends. The segment also highlights the challenges faced by pharmaceutical companies in meeting the rising demand for weight loss drugs and the potential risks to Oprah's reputation.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode